Hong NJ, Garvin JL. Nitric oxide reduces flow-induced superoxide production via cGMP-dependent protein kinase in thick ascending limbs. Am J Physiol Renal Physiol 296: F1061-F1066, 2009. First published February 25, 2009 doi:10.1152/ajprenal.90707.2008.-We have shown that increased luminal flow induces O 2 Ϫ and nitric oxide (NO) production in thick ascending limbs (TALs). However, the interaction of flow-stimulated NO and O 2 Ϫ in TALs is unclear. We hypothesized that NO inhibits flow-induced O 2 Ϫ production in TALs via cGMPdependent protein kinase (PKG). We measured flow-stimulated O 2 Ϫ production in rat TALs using dihydroethidium in the absence and presence of L-arginine (0.3 mM), the substrate for NO synthase. The addition of L-arginine reduced flow-induced net O 2 Ϫ production from 68 Ϯ 9 to 17 Ϯ 4 AU/s (P Ͻ 0.002). The addition of the NO synthase inhibitor Ϫ from 39 Ϯ 9 to 7 Ϯ 3 AU/s (P Ͻ 0.03). The PKG inhibitor KT-5823 (5 M) partially restored flow-induced net O 2 Ϫ in the presence of L-arginine (L-arginine: 4 Ϯ 4 AU/s vs. L-arginine ϩ KT-5823: 32 Ϯ 9 AU/s; P Ͻ 0.03) and db-cGMP (db-cGMP: 9 Ϯ 7 AU/s vs. db-cGMP ϩ KT-5823: 54 Ϯ 5 AU/s; P Ͻ 0.01). Phosphodiesterase II inhibition had no effect on arginine-inhibited O 2 Ϫ production. We conclude that 1) NO reduces flow-stimulated O 2 Ϫ production, 2) this occurs primarily via the cGMP/PKG pathway, and 3) O 2 Ϫ scavenging by NO plays a minor role.
reactive oxygen species; soluble guanylate cyclase; phosphodiesterase; scavenging NITRIC OXIDE (NO) and superoxide (O 2 Ϫ ) regulate kidney function, and consequently blood pressure. NO promotes natriuresis and diuresis, and therefore reductions in blood pressure. O 2 Ϫ promotes salt and water retention, and thus favors increases in blood pressure. Changes in natriuresis and urinary volume caused by these two reactive oxygen species can be due to alterations in renal hemodynamics or ion transport along the nephron. In the thick ascending limb, NO inhibits NaCl reabsorption (27, 30, 33, 34) . In contrast, O 2 Ϫ stimulates it (16, 17, 26, 41) . Perturbations in production or degradation of NO or O 2 Ϫ can lead to hypertension (1, 4, 36) and/or renal injury (2) . NO is synthesized from L-arginine in the thick ascending limb by NO synthase 3 (NOS3). Thus, in the absence of exogenously added L-arginine, thick ascending limbs do not generate NO (25) . Several factors stimulate NO production in this nephron segment, including angiotensin (5, 35) , ␣-2 adrenergic agonists (31, 45) , endothelin (13, 32) , and luminal flow (28, 29) . Once generated, NO activates soluble guanylate cyclase and forms cGMP (21) . cGMP, in turn, can activate two signaling cascades which are initiated by distinct enzymes: 1) cGMP-dependent protein kinase (PKG) and 2) cGMPstimulated phosphodiesterase. Most of the physiological effects of NO are mediated by cGMP (9, 23, 24, 42, 43) , but some may be mediated by other processes such as nitrosylation (39) .
Under basal conditions, thick ascending limbs generate O 2 Ϫ . Several enzymes may be involved in this process including NADPH oxidase (14, 19, 20, 46) . Similar to NO, NADPH oxidase may be activated by luminal flow (11, 14) . Luminal flow stimulates O 2 Ϫ production in this nephron segment by causing cellular stretch (11) and increasing NaCl transport (14) . NO can reduce O 2 Ϫ levels by a variety of mechanisms. NO has been shown to inhibit NADPH oxidase in human vascular smooth muscle cells (22) . It may also scavenge O 2 Ϫ through a chemical reaction forming peroxynitrite (ONOO Ϫ ) (15) . Finally, NO could reduce O 2 Ϫ levels by enhancing degradation, but this has not been described to date. Previously, we showed that O 2 Ϫ reduces NO in the thick ascending limb (25) , but whether flow-induced NO reduces flow-stimulated O 2 Ϫ in this segment and the mechanisms involved are unknown. We hypothesized that flow-induced NO diminishes flow-stimulated O 2 Ϫ production via an increase in cGMP and activation of PKG.
MATERIALS AND METHODS
Chemicals and solutions. Dihydroethidium was purchased from Molecular Probes/Invitrogen (Eugene, OR). LY-83583, a soluble guanylate cyclase inhibitor, and KT-5823, a PKG inhibitor, were obtained from Biomol International (Plymouth Meeting, PA). BAY 60-7550, a phosphodiesterase II inhibitor, was purchased from Axxora
were from Sigma (St. Louis, MO). The composition of physiological saline used to perfuse and bathe thick ascending limbs was (in mM) 130 NaCl, 2.5 NaH 2PO4, 4 KCl, 1.2 MgSO4, 6 L-alanine, 1 trisodium citrate, 5.5 glucose, 2 calcium dilactate, and 10 HEPES, pH 7.4 at 37°C. Osmolality was adjusted to 290 Ϯ 3 mosmol/ kgH 2O. Inhibitors and L-arginine (0.3 mM) were added to the bath.
Isolation and perfusion of rat thick ascending limb. All protocols involving animals were approved by the Institutional Animal Care and Use Committee. Male Sprague-Dawley rats (Charles River Breeding Laboratories, Wilmington, MA) maintained on a diet containing 0.22% sodium and 1.1% potassium (Purina, Richmond, IN) for at least 5 days and weighing 120 -150 g were used. Medullary thick ascending limbs were dissected from the outer medulla of coronal slices of the left kidney at 4 -10°C. Tubules were perfused at 20 nl/min as described previously (10) .
Measurement of O 2 Ϫ using dihydroethidium. Thick ascending limbs were loaded by bathing tubules in 10 M dihydroethidium for 15 min and then washing them in dye-free solution for 20 min. Oxyethidium and dihydroethidium were excited using 490 and 365 nm light, respectively. Emitted fluorescence was measured between 520 and 600 nm (oxyethidium) and 400 and 450 nm (dihydroethidium) from regions of interest (ROI). Fluorescence was recorded using Metafluor version 7 (Universal Imaging, Downingtown, PA). O 2 Ϫ was measured at the beginning of each period once every 5 s for 1 min. Regression analysis was performed and differences in slopes were statistically evaluated. The format for all protocols was that O 2 Ϫ was measured in a tubule in the absence of luminal flow and then again after luminal flow was initiated (control period). Flow was then stopped. In the same tubule, L-arginine and/or an inhibitor was added. After 15 min, O 2 Ϫ measurements were recorded again in the absence and presence of flow (experimental period).
The reaction between dihydroethidium and O 2 Ϫ is driven by O 2 Ϫ concentration and is irreversible. However, O 2 Ϫ concentration is determined by both production and degradation. Consequently, the rate of change of the oxyethidium/dihydroethidium fluorescence ratio is a measure of "net O 2 Ϫ production" (production Ϫ degradation), although it is commonly referred to as O 2 Ϫ production (7, 44) . Given that net O 2 Ϫ production represents production minus degradation, it may decrease when degradation is enhanced or production is reduced without indicating whether the former, latter, or both has/have occurred. Consequently, O 2 Ϫ measurements in this study will be referred to as net O 2 Ϫ production. Statistical analysis. Results are expressed as means Ϯ SE. Data were evaluated with ANOVA for repeated measures with two factors, flow and treatment. The difference in net O 2 Ϫ production for no flow vs. flow during the control period was compared with that during the experimental period, and P Ͻ 0.05 was considered significant.
RESULTS

To study whether NO affects the flow-induced increase in net O 2
Ϫ production, we subjected isolated thick ascending limbs to enhanced luminal flow in the absence and presence of the substrate for NOS, L-arginine. Figure 1A shows that in tubules with no luminal flow, net O 2 Ϫ production was 3 Ϯ 1 AU/s. After flow was initiated, it increased to 70 Ϯ 9 AU/s. Thus, flow increased net O 2 Ϫ production by 68 Ϯ 9 AU/s (control). In the presence of L-arginine (0.3 mM), net O 2 Ϫ production was 4 Ϯ 1 AU/s in the absence of flow, and it rose to 21 Ϯ 3 AU/s when flow was increased (P Ͻ 0.002; n ϭ 5 vs. control). Thus, arginine decreased flow-induced net O 2 Ϫ production by 75% to 17 Ϯ 4 AU/s (Fig. 1B ). To examine whether the effect of L-arginine on flow-induced net O 2 Ϫ production is due to NO produced by NOS, we used the NOS inhibitor L-NAME. Figure 2 shows that in the presence of L-arginine, flow stimulated net O 2 Ϫ production from 3 Ϯ 2 to 18 Ϯ 4 AU/s, a flow-induced increase of 15 Ϯ 4 AU/s. In the presence of L-arginine plus 5 mM L-NAME, flow enhanced net O 2 Ϫ production from 4 Ϯ 2 to 67 Ϯ 7 AU/s, a flow-induced increase of 63 Ϯ 7 AU/s (P Ͻ 0.002; n ϭ 5 vs. L-arginine alone). This value was similar to the effect of flow in the absence of L-arginine. In separate experiments, L-NAME alone had no effect on flow-induced net O 2 Ϫ production vs. nontreated tubules (data not shown). Therefore, the effect of L-arginine on net O 2 Ϫ production is due to endogenously produced NO.
The reduction in O 2 Ϫ caused by NO could be due to either scavenging (15) or inhibition of O 2 Ϫ production by NO via its second messenger cGMP (8, 22) . To study which is responsible, we used the soluble guanylate cyclase inhibitor LY-83583. First, we tested the effect of LY-83583 on the change in net O 2 Ϫ production induced by flow in the presence of L-arginine (Fig. 3, A and B) . In the presence of L-arginine, flow increased net O 2 Ϫ production from 4 Ϯ 2 to 11 Ϯ 4 AU/s. In the presence of 10 M LY-83583 plus L-arginine, flow increased net O 2 Ϫ production from 3 Ϯ 1 to 56 Ϯ 7 AU/s, a flow-induced increase of 53 Ϯ 7 AU/s (P Ͻ 0.01; n ϭ 5 vs. L-arginine alone).
To rule out the possibility that LY-835823 itself increases O 2 Ϫ , we next tested the effect of L-arginine in the presence of LY-83583 (Fig. 3, C and D) . In the presence of LY-83583 (10 M), flow stimulated net O 2 Ϫ production from 3 Ϯ 2 to 83 Ϯ 7 AU/s, an increase of 80 Ϯ 7 AU/s. When L-arginine was added in the presence of LY-83583, flow stimulated net O 2 Ϫ production from 3 Ϯ 1 to 54 Ϯ 3 AU/s (P Ͻ 0.006, n ϭ 5 vs. LY-83583 alone), an increase of 51 Ϯ 3 AU/s. Thus, L-arginine reduced flow-induced net O 2 Ϫ production by 36% in the presence of LY-83583, significantly less than the 75% inhibition caused by L-arginine in the absence of LY-83583 (Fig. 1B) .
If NO-stimulated cGMP decreases net O 2 Ϫ production, then db-cGMP, a cGMP analog, should mimic this effect. Figure 4 shows that during the control period, flow stimulated net O 2 Ϫ production from 8 Ϯ 2 to 47 Ϯ 9 AU/s, an increase of 39 Ϯ 9 AU/s. In the presence of 0.1 mM db-cGMP, flow stimulated net O 2 Ϫ production from 3 Ϯ 1 to 10 Ϯ 3 AU/s, an increase of only 7 Ϯ 3 AU/s (P Ͻ 0.03; n ϭ 5 vs. control). Most of the effects of cGMP on thick ascending limb function are mediated by either PKG (23) or phosphodiesterase II (PDE2) (24) . Therefore, we investigated which is involved in NO's ability to inhibit flow-induced net O 2 Ϫ production. First, we tested the effect of the PKG inhibitor KT-5823 (Fig. 5, A and B) . Next, we tested whether KT-5823 could also block the effects of db-cGMP (Fig. 5, C and D) . In the presence of db-cGMP, flow stimulated net O 2 Ϫ production from 4 Ϯ 2 to 13 Ϯ 6 AU/s, an increase of 9 Ϯ 7 AU/s. In the presence of 5 M KT-5823, flow stimulated net O 2 Ϫ from 4 Ϯ 3 to 58 Ϯ 6 AU/s, an increase of 54 Ϯ 5 AU/s (P Ͻ 0.01; n ϭ 5 vs. db-cGMP alone).
To determine whether PDE2 is involved in the effect of arginine/NO on flow-stimulated net O 2 Ϫ production, we used the PDE2 inhibitor BAY 60 -7550 (Fig. 6) . BAY 60 -7550 (100 nM) did not significantly change arginine's effect on flow-induced net O 2 Ϫ production (L-arginine alone ⌬: 6 Ϯ 2 AU/s vs. L-arginine plus BAY 60 -7550 ⌬: 10 Ϯ 4 AU/s; n ϭ 5).
DISCUSSION
Our hypothesis was that flow-induced NO diminishes flowstimulated net O 2 Ϫ production via an increase in cGMP and activation of PKG. To test this hypothesis, we first studied the effect of L-arginine on flow-induced net O 2 Ϫ production. We used L-arginine because we previously showed that addition of arginine to the bath of isolated thick ascending limbs stimulates NO production (25) , whereas in its absence thick ascending limbs do not produce NO. We found that L-arginine reduced flow-stimulated net O 2 Ϫ production by ϳ70%. However, Larginine had no effect on O 2 Ϫ in the absence of luminal flow. To show that this effect was in fact due to NO, we tested whether the competitive inhibitor of NO production, L-NAME, could block the effects of L-arginine. We found that in the presence of L-NAME, L-arginine no longer had any significant effect on net O 2 Ϫ production in the presence or absence of luminal flow. L-NAME alone did not change net O 2 Ϫ production compared with nontreated tubules, suggesting that O 2 Ϫ produced by uncoupled NOS is not involved. Taken together, these data indicate that flow-induced NO diminishes flowstimulated net O 2 Ϫ production. However, NO does not completely prevent flow from enhancing net O 2 Ϫ production. About 20% of flow-induced O 2 Ϫ appears to be insensitive to the effects of NO. To our knowledge, this is the first study investigating the interaction of NO and O 2 Ϫ in thick ascending limbs.
NO and O 2 Ϫ can react if they are formed simultaneously in the same compartment. This reaction proceeds at a rate of at least 6 ϫ 10 9 mol⅐l Ϫ1 ⅐s Ϫ1 (15) . This rapid rate is primarily due to the fact that both NO and O 2 Ϫ are free radicals, with an unpaired electron in the outer valence shell. Given that 20% of net O 2 Ϫ is NO insensitive, our data suggest that at least part of flow-induced O 2 Ϫ is generated in a compartment different from flow-stimulated NO.
Most of the effects of NO are mediated by cGMP (9, 23, 24, 42, 43) . Thus, NO could reduce flow-induced net O 2 Ϫ production either by scavenging O 2 Ϫ or by affecting degradation or production via cGMP. To investigate which predominates in thick ascending limbs, we first used an inhibitor of soluble guanylate cyclase, LY-83583. When LY-83583 was added to the bath in the presence of L-arginine, it restored the ability of flow to stimulate net O 2 Ϫ production. These data indicate that some of the inhibitory effect of NO on net O 2 Ϫ production is mediated by cGMP. However, this experimental design does not allow one to estimate how much of this effect is mediated by cGMP. To do this, we reversed the experiment and added L-arginine in the presence of LY-83583. Under these conditions, we found that L-arginine only reduced flow-stimulated net O 2 Ϫ production by ϳ35%. Given that inhibition of soluble guanylate cyclase prevented 70% of NO's inhibition, we next tested whether a cGMP analog would mimic the effect of NO. We found that db-cGMP also reduced flow-induced net O 2 Ϫ production. Taken together, these data indicate that cGMP mediates ϳ70% of the inhibitory effect of L-arginine on net O 2 Ϫ production. They also indicate that LY-83583 alone does not affect O 2 Ϫ production. cGMP can activate a number of enzymes, including PKG and PDE2. To test whether either is involved in NO-induced inhibition of net O 2 Ϫ production, we used KT-5823 and BAY-60 -7550, inhibitors of PKG and PDE2, respectively. We found that inhibition of PKG with KT-5823 blocked the effects of both arginine and cGMP on net O 2 Ϫ production. In contrast, PDE2 inhibition did not change the effect of arginine on flow-stimulated net O 2 Ϫ production. Taken together, these data indicate that flow-induced net O 2 Ϫ production in the thick ascending limb is reduced by endogenously produced NO and that a cGMP-dependent pathway mediated by PKG, rather than PDE2/cAMP, is involved. To our knowledge, this is the first study to demonstrate that a significant portion of NO's effect on flow-induced net O 2 Ϫ production in the thick ascending limb is due to a cGMP/PKG-mediated process rather than scavenging.
Our data suggest that a majority of the observed decrease in net O 2 Ϫ production caused by NO is due to a PKG-mediated process. However, we did find that a small proportion of the inhibition was not mediated by PKG. The most likely explanation for the non-PKG-mediated inhibition is scavenging of O 2 Ϫ by NO. However, it is also possible that nitrosylation is involved. Nitrosylation could inactivate the source of O 2 Ϫ (39) or a regulatory protein, or activate an enzyme responsible for O 2 Ϫ degradation. We unexpectedly found that most of the reduction of net O 2 Ϫ production was not due to scavenging. Unfortunately, due to the nature of this study using isolated, perfused tubules, it is technically impossible to measure peroxynitrite production. However, it would be interesting to explore other stimuli of NO and O 2 Ϫ to study the relative contributions of such processes as scavenging, nitrosylation, and cGMP/PKG signaling.
Given that we previously showed that flow-stimulated O 2 Ϫ production is due to activation of NADPH oxidase, our data showing that NO reduces net O 2 Ϫ production are consistent with other studies. Fujii et al. (8) found that arginine inactivated p47 phox in the renal cortex of Dahl salt-sensitive rats, which should reduce O 2 Ϫ production by preventing NADPH oxidase assembly. These authors assumed that the effect was due to enhanced NO synthesis, but did not test that hypothesis. Muzaffar et al. (22) showed that NO acutely inhibits O 2 Ϫ production in human vascular smooth muscle cells by blocking translocation of the NADPH oxidase subunit p47 phox . They also found that NO's effect on O 2 Ϫ production could be blocked by a PKG inhibitor (22) similar to our results.
The mechanism by which PKG inhibits net O 2 Ϫ production in the thick ascending limb is unknown. Either production, degradation, or both may be affected. To our knowledge, there are currently no known effects of cGMP or PKG on enzymes involved in O 2 Ϫ degradation. Thus, it is likely that PKGdependent inhibition of net O 2 Ϫ production is due to reduced synthesis. As discussed above, flow-induced O 2 Ϫ is a result of NADPH oxidase activation. Consequently, PKG may reduce net O 2 Ϫ production by blocking p47 phox translocation as has been reported in vascular smooth muscle cells (22) . Protein kinase C (PKC) may also play a role. PKG phosphorylates (12) and inhibits PKC (18) . PKC is required for assembly of p47 phox with other subunits to form active NADPH oxidase (3, 40) . Finally, PKG may inhibit one or more steps involved with sensing increased luminal flow.
Luminal flow through the thick ascending limb varies over a wide range (6, 37, 38) . Production of O 2 Ϫ in response to increased luminal flow is not an on/off process. We previously showed that O 2 Ϫ production is linearly related to flow rate in the physiological range of 0 to 20 nl/min (14) . We also observed that NO production is linearly related to flow. Although we did not use different flow rates in this study, we would expect a similar relationship between flow rate and O 2 Ϫ production. In summary, we found that NO attenuates flow-stimulated O 2 Ϫ production in the thick ascending limb via a cGMP/PKG pathway. The complexity of actions and interactions of these two factors helps regulate important cellular functions in the kidney, such as salt and water reabsorption. In addition to having direct natriuretic effects, NO keeps in check the potential deleterious effects of enhanced O 2 Ϫ induced by increases in flow. O 2 Ϫ stimulates Na absorption in the thick ascending limb. Thus, understanding the processes involved in maintaining NO and O 2 Ϫ balance may give insight into the pathogenesis and treatment of diseases associated with Na retention and oxidative stress.
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